VC

Viren Chandrakant Sheth

Active Director Designated Partner DIN 11188399
DIN 11188399 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Viren Chandrakant Sheth

Data last updated:

Viren Chandrakant Sheth is a Designated Partner at Serengeti Pharma Llp (since 2025).

DIN 11188399
Primary Designation Designated Partner
First Appointment 07 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Jul 20252025Active

Board colleagues of Viren Chandrakant Sheth

NameDINCompanyDesignation
Minolbhai Bhagvandas Amin07572398Serengeti Pharma LlpDesignated Partner
Rajeshkumar Navinchandra Thakkar11188398Serengeti Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Serengeti Pharma Llp
Premium access

Shareholding and investment profile for Viren Chandrakant Sheth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Viren Chandrakant Sheth

Viren Chandrakant Sheth currently holds 1 directorship: Serengeti Pharma Llp (Designated Partner, since 07 Jul 2025).

Viren Chandrakant Sheth was first appointed on 07 Jul 2025 as Designated Partner at Serengeti Pharma Llp.

The current boards of Viren Chandrakant Sheth's companies include Minolbhai Bhagvandas Amin (Serengeti Pharma Llp), Rajeshkumar Navinchandra Thakkar (Serengeti Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available